Towa Pharmaceutical Co., Ltd.

¥3,310As of Sun 8 Nov 2026, 12:00 UTC
TSE:4553Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 11.95%
Div yield 2.57%
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.08)
PE TTM 19.71
TSR TTM 19.21%
Mkt cap ¥163.0B
ROIC 3.22%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3,213
(2.94%)
(70.40%)
Hold 4|8|1|9|6
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
32.21
31.96
35.76
35.30
(7.01%)
(4.64%)
6.99%
7.50%
Revenue¥B
10.16
10.75
10.77
10.95
3.71%
4.10%
3.30%
5.26%
Peers (US$1.035B)
Cap (US$)
PE
1.045B
—
Capital
TTM
5Y
10Y
Leveragex
3.068
0.605
0.502
EBIT/Intx
11.23
0.066
0.063
Own earn%
(21.72)
(188.41)
(202.88)
Sh yield%
15.68
18.86
19.12
Owners
Insiders/Inst%
8.15
64.45
Short interest%
5.91
SBC / revenue%
3.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
8–20
$1 testx
—
Incr. ROIC%
2